ARCH ONCOLOGY
At Arch Oncology, they are aiming high to discover and develop new antibody therapeutics to treat patients living with cancer. They are committed to advancing antibodies with best-in-class potential.Their next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class.
ARCH ONCOLOGY
Social Links:
Industry:
Biotechnology
Founded:
2006-11-21
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.archoncology.com
Total Employee:
11+
Status:
Active
Total Funding:
155 M USD
Similar Organizations
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
CareDx
CareDx is a novel molecular diagnostics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series C - Arch Oncology
Avego Healthcare Capital
Avego Healthcare Capital investment in Series C - Arch Oncology
Broadfin Capital
Broadfin Capital investment in Series C - Arch Oncology
Lightchain
Lightchain investment in Series C - Arch Oncology
3×5 Partners
3×5 Partners investment in Series C - Arch Oncology
RiverVest
RiverVest investment in Series C - Arch Oncology
FMB Research
FMB Research investment in Series C - Arch Oncology
Adage Capital Management
Adage Capital Management investment in Series C - Arch Oncology
Eventide
Eventide investment in Series C - Arch Oncology
Roche Venture Fund
Roche Venture Fund investment in Series C - Arch Oncology
Official Site Inspections
http://www.archoncology.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K
- Host name: 106.233.71.198.host.secureserver.net
- IP address: 198.71.233.106
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Arch Oncology"
Arch Oncology - Crunchbase Company Profile & Funding
Arch Oncology is an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. The company's …See details»
Arch Oncology - Craft
Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. The Company's …See details»
Arch Oncology Company Profile | Management and Employees …
Arch Oncology Profile and History Arch Oncology, Inc. was founded in 2006 out of Brisbane, California, they are a privately-held, clinical-stage immuno-oncology company focused on the …See details»
Arch Oncology: Contact Details and Business Profile - RocketReach
Arch Oncology is a Biotechnology Research, Immuno-oncology, and Drug Development company_reader located in Brisbane, California with 23 employees. Find top employees, …See details»
Arch Oncology Company Overview, Contact Details & Competitors …
Apr 27, 2021 Learn more about Arch Oncology's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Arch Oncology 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Arch Oncology. Use the PitchBook Platform to explore the full profile.See details»
Arch Oncology - Overview, News & Similar companies - ZoomInfo
May 22, 2021 View Arch Oncology (www.archoncology.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Arch Oncology - Contacts, Employees, Board Members, Advisors …
Arch Oncology has 9 current employee profiles, including President & CEO Laurence Blumberg. Arch Oncology has 9 board members and advisors, including Julie Hambleton.Arch Oncology …See details»
Arch Oncology (USA) Funding: $250.4M - Medical Startups
Arch Oncology is aiming high to discover and develop new antibody therapeutics to treat patients living with cancer. It's committed to advancing antibodies with best-in-class potential.See details»
ArchOncology Home: Revenue, Worth, Valuation & Competitors …
About ArchOncology Home ArchOncology Home is a Biotech related company based in Brisbane with an estimated revenue of $1.6M, and 10 employees. It has 10 competitors including …See details»
Arch Oncology CEO and Key Executive Team - Craft.co
Arch Oncology's Chairman is John McKearn. Other executives include Daniel Pereira, Chief Scientific Officer; Arun Kashyap, Vice President, Research and 1 others. See the full …See details»
Archoncology Security Rating - SecurityScorecard
View Archoncology's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving ArchoncologySee details»
Arch Oncology – Funding, Valuation, Investors, News
Arch Oncology, Inc. is a clinical-stage immuno-oncology company focused on the discovery and development of potential best-in-class antibody therapies for the treatment of patients with …See details»
Arch Oncology, Inc. - Rivervest
With RiverVest as a founder, Arch Oncology is focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with solid-tumor and certain blood …See details»
Arch Oncology Appoints Laurence Blumberg, M.D. President
Apr 7, 2021 Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of potential best-in-class antibody therapies for the …See details»
Arch Oncology Overview | SignalHire Company Profile
Overview Arch Oncology is a private company that has been in the industry for 17 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the …See details»
Roche-backed Arch Oncology gets off $50M round for anti-CD47 …
Mar 25, 2019 Just weeks after kick-starting its phase 1 test, Arch Oncology has gathered $50 million in financing to help see its immuno-oncology asset through the clinic.See details»
BioGenerator Company Arch Oncology Closes $105M Series C
LOUIS, April 27, 2021 (GLOBE NEWSWIRE) -- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of anti-CD47 biologic therapies, …See details»
archoncology.com - ArchOncology Home - Arch Oncol... - Arch …
Archoncology.com. At Arch Oncology, we are aiming high to discover and develop new antibody therapeutics to treat patients living with cancer.See details»
Arch Oncology Secures $105 Million Series C Financing
Apr 27, 2021 Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of potential best-in-class biologic therapies for the …See details»